Author: Lin, Huayuan; Huang, Qiqi; Guo, Xiaoquan; Liu, Ping; Liu, Weilian; Zou, Yuelong; Zhu, Shuliang; Deng, Guangfu; Kuang, Jun; Zhang, Caiying; Cao, Huabin; Hu, Guoliang
Title: Elevated level of renal xanthine oxidase mRNA transcription after nephropathogenic infectious bronchitis virus infection in growing layers Document date: 2015_12_17
ID: t8547tse_19
Snippet: Figs. 1-3 show the serum XOD, GSH-PX and SOD activity in the infected group and control group at 8, 15 and 22 dpi, individually. At 8 and 15 dpi, the serum activity of XOD in the infected group had increased significantly when compared with the control group (p ＜ 0.01), and a significant increase was observed at 22 dpi (p ＜ 0.05; Fig. 1 ). GSH-PX and SOD activities were statistically lower than in the control group at 8 dpi and 15 dpi (p ＜ .....
Document: Figs. 1-3 show the serum XOD, GSH-PX and SOD activity in the infected group and control group at 8, 15 and 22 dpi, individually. At 8 and 15 dpi, the serum activity of XOD in the infected group had increased significantly when compared with the control group (p ＜ 0.01), and a significant increase was observed at 22 dpi (p ＜ 0.05; Fig. 1 ). GSH-PX and SOD activities were statistically lower than in the control group at 8 dpi and 15 dpi (p ＜ 0.01; GSH-PX, Fig. 2; SOD, Fig. 3 ). At 22 dpi, SOD and GSH-PX did not differ significantly, but a steadily decreasing trend between infected and control groups was observed.
Search related documents:
Co phrase search for related documents- control group and infected group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- control group and infected group XOD serum activity: 1
- control group and serum activity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
- control group and serum xod: 1, 2
- control group and significant increase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- control group and significantly differ: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- control group and significantly increase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- control group and XOD serum activity: 1, 2
- control group group and infected control group group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- control group group and infected group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- control group group and infected group XOD serum activity: 1
- control group group and serum activity: 1, 2, 3, 4, 5, 6, 7, 8, 9
- control group group and serum xod: 1, 2
- control group group and significant increase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- control group group and significantly differ: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- control group group and significantly increase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- control group group and XOD serum activity: 1, 2
- control infected group and infected control group group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- control infected group and infected group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
Co phrase search for related documents, hyperlinks ordered by date